Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Nesina (alogliptin) for Treatment of Type 2 Diabetes Mellitus

Drug Name (Brand / Generic)

Nesina / alogliptin

Therapy Class

DPP-4 Inhibitor

Company / Licensee

Takeda Pharmaceuticals / Furiex Pharmaceuticals

Current Indication

Type II Diabetes Mellitus

Market Sector

Diabetes

Development Status

Approved in the US and Japan
Expand
Close
Close
Close

Go Top